Skip to content

The study on pathogenesis of adenovirus viremia in children

The study on pathogenesis of adenovirus viremia in children

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200063040
Enrollment
Unknown
Registered
2022-08-29
Start date
2022-08-30
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenovirus infection and Adenoviremia in children

Interventions

Group 1 :
Group 2:

Sponsors

Children’s Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Children with adenovirus infection and screening for blood adenovirus PCR.

Exclusion criteria

Exclusion criteria: Children with immunodeficiency, children with malignant diseases of the blood system, children with long-term oral steroids or immunosuppressants.

Design outcomes

Primary

MeasureTime frame
Cytokines;Lymphocyte absolute count;survive;death;Detection of copy number of adenovirus in respiratory secretions by PCR;Detection of copy number and positive duration of adenovirus by PCR in blood;Child Death Index -3;

Secondary

MeasureTime frame
Vascular endothelial cell damage markers;respiratory failure;Lymphocyte absolute value;Hemoglobin;platelet;total white blood cells;Procalcitonin;C reactive protein;Alanine aminotransferase;lactate dehydrogenase;creatinine;Myocardial markers;B-type brain natriuretic peptide;prothrombin time;D-dimer;Fibrinogen;activated partial thromboplastin time, APTT;Mechanical Ventilation;pediatric sequential organ failure score;

Countries

China

Contacts

Public ContactFu Yueqiang

Children’s Hospital of Chongqing Medical University

fuyueqiang@sina.com+86 15123134328

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026